Related Articles
Enhanced antitumor effect of combination intravesical mitomycin C and bacillus Calmette-Guerin therapy in an orthotopic bladder cancer model
Changes in mucosal immune cells of bladder tumor patient after BCG intravesical immunotherapy
Comparison of intravesical bacillus Calmette‑Guerin and mitomycin C administration for non‑muscle invasive bladder cancer: A meta‑analysis and systematic review
Significance of target cell infection and natural killer cells in the anti-tumor effects of bacillus Calmette-Guerin in murine bladder cancer
Production of IL-5, a classical T(H)2 cytokine, following bacillus Calmette guerin immunotherapy of bladder cancer